{"id":"https://openalex.org/W3013558293","doi":"https://doi.org/10.1210/clinem/dgaa149","title":"Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes","display_name":"Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes","publication_year":2020,"publication_date":"2020-03-27","ids":{"openalex":"https://openalex.org/W3013558293","doi":"https://doi.org/10.1210/clinem/dgaa149","mag":"3013558293","pmid":"https://pubmed.ncbi.nlm.nih.gov/32219329"},"language":"en","primary_location":{"id":"doi:10.1210/clinem/dgaa149","doi":"https://doi.org/10.1210/clinem/dgaa149","is_oa":false,"landing_page_url":"https://doi.org/10.1210/clinem/dgaa149","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://academic.oup.com/jcem/article-pdf/105/6/e2192/41829538/jcem_105_6_e2192.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087265840","display_name":"Paolo Pozzilli","orcid":"https://orcid.org/0000-0001-5090-636X","observed_orcids":["https://orcid.org/0000-0001-5090-636X"]},"institutions":[{"id":"https://openalex.org/I155125353","display_name":"Universit\u00e0 Campus Bio-Medico","ror":"https://ror.org/04gqx4x78","country_code":"IT","type":"education","lineage":["https://openalex.org/I155125353"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Paolo Pozzilli","raw_affiliation_strings":["University of Rome, Campus Bio-Medico, Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0001-5090-636X","affiliations":[{"raw_affiliation_string":"University of Rome, Campus Bio-Medico, Rome, Italy","institution_ids":["https://openalex.org/I155125353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017456380","display_name":"Emanuele Bosi","orcid":"https://orcid.org/0000-0002-2371-2495","observed_orcids":["https://orcid.org/0000-0002-2371-2495"]},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]},{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387155925","display_name":"IRCCS San Raffaele Roma","ror":"https://ror.org/006x48140","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387155925"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Bosi","raw_affiliation_strings":["Diabetes Research Institute, IRCCS San Raffaele and San Raffaele Vita Salute University, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Institute, IRCCS San Raffaele and San Raffaele Vita Salute University, Milan, Italy","institution_ids":["https://openalex.org/I154387261","https://openalex.org/I4210133214","https://openalex.org/I4387155925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050151766","display_name":"Deborah T. Cirkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deborah Cirkel","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041744672","display_name":"Julia Harris","orcid":"https://orcid.org/0000-0002-9111-047X","observed_orcids":["https://orcid.org/0000-0002-9111-047X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Julia Harris","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031650001","display_name":"Nicola Leech","orcid":"https://orcid.org/0000-0003-0300-2290","observed_orcids":["https://orcid.org/0000-0003-0300-2290"]},"institutions":[{"id":"https://openalex.org/I2801663869","display_name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","ror":"https://ror.org/05p40t847","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Leech","raw_affiliation_strings":["The Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2801663869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061677162","display_name":"Francisco Jos\u00e9 Tinahones","orcid":"https://orcid.org/0000-0001-6871-4403","observed_orcids":["https://orcid.org/0000-0001-6871-4403"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2801724371","display_name":"Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition","ror":"https://ror.org/02s65tk16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801724371"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210164724","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga","ror":"https://ror.org/05n3asa33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210164724"]},{"id":"https://openalex.org/I82767444","display_name":"Universidad de M\u00e1laga","ror":"https://ror.org/036b2ww28","country_code":"ES","type":"education","lineage":["https://openalex.org/I82767444"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco J Tinahones","raw_affiliation_strings":["Department of Endocrinology and Nutrition, Virgen de la Victoria Hospital (IBIMA), Malaga University. Centro de Investigaci\u00f3n Biom\u00e9dica en Red de la Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III (ISCIII), M\u00e1laga, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Nutrition, Virgen de la Victoria Hospital (IBIMA), Malaga University. Centro de Investigaci\u00f3n Biom\u00e9dica en Red de la Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III (ISCIII), M\u00e1laga, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2801724371","https://openalex.org/I4210115082","https://openalex.org/I4210164724","https://openalex.org/I82767444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044106914","display_name":"Marie\u2010Christine Vantyghem","orcid":"https://orcid.org/0000-0002-9369-0463","observed_orcids":["https://orcid.org/0000-0002-9369-0463"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210167107","display_name":"European Genomic Institute for Diabetes","ror":"https://ror.org/05n2c8735","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210167107"]},{"id":"https://openalex.org/I4387154483","display_name":"Recherche translationnelle sur le diab\u00e8te et les troubles m\u00e9taboliques","ror":"https://ror.org/03pbmtd68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210167107","https://openalex.org/I4387154483"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Christine Vantyghem","raw_affiliation_strings":["University of Lille, CHU Lille, Endocrinology, Diabetology and Metabolism Department, Inserm U1190\u2014European Genomic Institute for Diabetes, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Lille, CHU Lille, Endocrinology, Diabetology and Metabolism Department, Inserm U1190\u2014European Genomic Institute for Diabetes, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210167107","https://openalex.org/I4387154483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083112543","display_name":"Georgios Vlasakakis","orcid":"https://orcid.org/0000-0002-7390-9712","observed_orcids":["https://orcid.org/0000-0002-7390-9712"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Georgios Vlasakakis","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062338037","display_name":"Anette\u2010Gabriele Ziegler","orcid":"https://orcid.org/0000-0002-6290-5548","observed_orcids":["https://orcid.org/0000-0002-6290-5548"]},"institutions":[{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"id":"https://openalex.org/I3018134672","display_name":"Helmholtz Munich","ror":"https://ror.org/00cfam450","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I3018134672"]},{"id":"https://openalex.org/I4387152912","display_name":"Institute of Diabetes Research","ror":"https://ror.org/0278hns33","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I3018134672","https://openalex.org/I4387152912"]},{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anette-Gabriele Ziegler","raw_affiliation_strings":["Institute of Diabetes Research, Helmholtz Zentrum M\u00fcnchen, Germany, and Forschergruppe Diabetes, Technical University Munich, at Klinikum rechts der Isar, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Diabetes Research, Helmholtz Zentrum M\u00fcnchen, Germany, and Forschergruppe Diabetes, Technical University Munich, at Klinikum rechts der Isar, Munich, Germany","institution_ids":["https://openalex.org/I2802619606","https://openalex.org/I3018134672","https://openalex.org/I4387152912","https://openalex.org/I62916508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058902714","display_name":"Salim G. Janmohamed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Salim Janmohamed","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":20,"corresponding_author_ids":["https://openalex.org/A5087265840"],"corresponding_institution_ids":["https://openalex.org/I155125353"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":3.9614,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.94826406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"105","issue":"6","first_page":"e2192","last_page":"e2206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.3734999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9559999704360962},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9179999828338623},{"id":"https://openalex.org/keywords/residual-beta-cell-function","display_name":"residual beta-cell function","score":0.8389999866485596},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.9629999995231628},{"id":"https://openalex.org/keywords/newly-diagnosed-diabetes","display_name":"newly diagnosed diabetes","score":0.671999990940094},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.7440000176429749},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8610000014305115},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8223669528961182},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.763651967048645},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6532521843910217},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6018129587173462},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5238492488861084},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5120046734809875},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4253637194633484},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3768681287765503},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3491072654724121},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33984023332595825},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.294992059469223},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1210/clinem/dgaa149","doi":"https://doi.org/10.1210/clinem/dgaa149","is_oa":false,"landing_page_url":"https://doi.org/10.1210/clinem/dgaa149","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology & Metabolism","raw_type":"journal-article"},{"id":"pmid:32219329","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32219329","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:www.repositoriosalud.es:10668/15294","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10668/15294","pdf_url":"https://academic.oup.com/jcem/article-pdf/105/6/e2192/41829538/jcem_105_6_e2192.pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},{"id":"pmh:oai:HAL:hal-04746263v1","doi":null,"is_oa":false,"landing_page_url":"https://lilloa.hal.science/hal-04746263","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Endocrinology and Metabolism, 2020, Journal of Clinical Endocrinology and Metabolism, 105, pp.e2192-e2206. ⟨10.1210/clinem/dgaa149⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1620522","doi":null,"is_oa":false,"landing_page_url":"https://mediatum.ub.tum.de/1620522","pdf_url":null,"source":{"id":"https://openalex.org/S4377196330","display_name":"mediaTUM  (Technical University of Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:opus-zb.helmholtz-muenchen.de:58722","doi":null,"is_oa":true,"landing_page_url":"https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=58722","pdf_url":null,"source":{"id":"https://openalex.org/S4377196115","display_name":"Site cant be reached","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J. Clin. Endocrinol. Metab. 105, e2192\u2013e2206 (2020)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:push-zb.helmholtz-munich.de:58722","doi":null,"is_oa":false,"landing_page_url":"https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=58722","pdf_url":null,"source":{"id":"https://openalex.org/S7407055352","display_name":"PuSH - Publication Server of Helmholtz Zentrum M\u00fcnchen","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J. Clin. Endocrinol. Metab. 105, e2192\u2013e2206 (2020)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:www.repositoriosalud.es:10668/15294","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10668/15294","pdf_url":"https://academic.oup.com/jcem/article-pdf/105/6/e2192/41829538/jcem_105_6_e2192.pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3013558293.pdf","grobid_xml":"https://content.openalex.org/works/W3013558293.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1565235211","https://openalex.org/W1967442749","https://openalex.org/W1983796537","https://openalex.org/W2005100580","https://openalex.org/W2019513002","https://openalex.org/W2024133102","https://openalex.org/W2094345654","https://openalex.org/W2109416725","https://openalex.org/W2118174270","https://openalex.org/W2139152163","https://openalex.org/W2139279363","https://openalex.org/W2147072756","https://openalex.org/W2151041093","https://openalex.org/W2159859567","https://openalex.org/W2160088494","https://openalex.org/W2166992787","https://openalex.org/W2172277730","https://openalex.org/W2184500611","https://openalex.org/W2429231050","https://openalex.org/W2494601841","https://openalex.org/W2514658869","https://openalex.org/W2626839453","https://openalex.org/W2772059359","https://openalex.org/W2894746763","https://openalex.org/W4235093819"],"related_works":["https://openalex.org/W2167934167","https://openalex.org/W1945841307","https://openalex.org/W2161551526","https://openalex.org/W2755926545","https://openalex.org/W4401968110","https://openalex.org/W2178377864","https://openalex.org/W1976503602","https://openalex.org/W2948739383","https://openalex.org/W2118848581","https://openalex.org/W2555729293"],"abstract_inverted_index":{"CONTEXT:":[0],"GLP-1":[1],"receptor":[2],"agonists":[3],"are":[4],"an":[5],"established":[6],"therapy":[7],"in":[8,17,47,90,138,194,215],"patients":[9,48,122,227],"with":[10,45,49,148,154,228],"type":[11,18,51,229],"2":[12,62],"diabetes;":[13],"however,":[14],"their":[15],"role":[16],"1":[19,52,230,239],"diabetes":[20,53],"remains":[21],"to":[22,36,135,234],"be":[23],"determined.":[24],"OBJECTIVE:":[25],"Determine":[26],"efficacy":[27],"and":[28,54,110,118,150,218],"safety":[29],"of":[30,112,180,221],"once-weekly":[31],"albiglutide":[32,232],"30":[33,233],"mg":[34,38,236],"(up-titration":[35],"50":[37,235],"at":[39,174,199],"week":[40,136,200],"6)":[41],"versus":[42,250],"placebo":[43,71,149],"together":[44],"insulin":[46,56],"new-onset":[50],"residual":[55,247],"production.":[57],"DESIGN:":[58],"52-week,":[59],"randomized,":[60],"phase":[61],"study":[63,163],"(NCT02284009).":[64],"METHODS:":[65],"A":[66,190],"prespecified":[67],"Bayesian":[68,159],"approach,":[69],"incorporating":[70],"data":[72],"from":[73,88,133],"a":[74,181],"prior":[75,162],"study,":[76,128],"allowed":[77],"for":[78,238],"3:1":[79],"(albiglutide:placebo)":[80],"randomization.":[81],"The":[82],"primary":[83,158],"endpoint":[84,206],"was":[85,144,172,187,197],"52-week":[86],"change":[87,132],"baseline":[89,134],"mixed":[91],"meal":[92],"tolerance":[93],"test":[94],"(MMTT)":[95],"stimulated":[96],"2-h":[97,140],"plasma":[98,141],"C-peptide":[99,142,196],"area":[100],"under":[101],"the":[102,124,157,165,178],"curve":[103],"(AUC).":[104],"Secondary":[105],"endpoints":[106],"included":[107],"metabolic":[108],"measures":[109],"pharmacokinetics":[111],"albiglutide.":[113,155],"RESULTS:":[114],"12/17":[115],"(70.6%,":[116],"placebo)":[117],"40/50":[119],"(80.0%,":[120],"albiglutide)":[121],"completed":[123],"study.":[125],"Within":[126],"our":[127],"mean":[129],"(standard":[130],"deviation)":[131],"52":[137],"MMTT-stimulated":[139],"AUC":[143],"-0.16":[145],"nmol/L":[146,152,176,184],"(0.366)":[147],"-0.13":[151],"(0.244)":[153],"For":[156],"analysis":[160],"(including":[161],"data)":[164],"posterior":[166],"treatment":[167],"difference":[168,182,193],"(95%":[169],"credible":[170],"interval)":[171],"estimated":[173],"0.12":[175],"(0-0.24);":[177],"probability":[179],"\u22650.2":[183],"between":[185],"treatments":[186],"low":[188],"(0.097).":[189],"transient":[191],"significant":[192,204],"maximum":[195],"seen":[198],"28.":[201],"Otherwise,":[202],"no":[203,242],"secondary":[205],"differences":[207],"were":[208,213],"noted.":[209],"On-therapy":[210],"adverse":[211],"events":[212],"reported":[214],"82.0%":[216],"(albiglutide)":[217],"76.5%":[219],"(placebo)":[220],"patients.":[222],"CONCLUSION:":[223],"In":[224],"newly":[225],"diagnosed":[226],"diabetes,":[231],"weekly":[237],"year":[240],"had":[241],"appreciable":[243],"effect":[244],"on":[245],"preserving":[246],"\u03b2-cell":[248],"function":[249],"placebo.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-04-03T00:00:00"}